Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study

Frontiers The Efficacy and Safety of Janus Kinase Inhibitors for

Post-COVID-19 interstitial lung disease presenting with profound

Nosocomial Infections in COVID-19 Patients Treated with

Baricitinib: From Rheumatoid Arthritis to COVID‐19 - Assadiasl

Frontiers Efficacy and safety of tocilizumab and baricitinib

Tocilizumab versus baricitinib in hospitalized patients with

Two Years into the COVID-19 Pandemic: Lessons Learned

Tocilizumab versus baricitinib in hospitalized patients with

Tocilizumab treatment for COVID-19 patients: a systematic review